Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added. The notices about government funding lapse and the previous Revision: v3.4.0 were removed.
    Difference
    0.4%
    Check dated 2026-02-09T14:54:54.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a glossary and adds QC-related metadata labels ('Last Update Submitted that Met QC Criteria') along with a revision note ('Revision: v3.4.0'), while older QC label, no-FEAR Act data note, and the prior revision label ('v3.3.4') were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T09:42:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T07:29:09.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added a Locations section listing Minnesota as the study site, and removed the Minnesota Locations entry and the HHS Vulnerability Disclosure link. The page revision was updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-21T23:26:47.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T10:12:32.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.1. There are no changes to study details or page content.
    Difference
    0.1%
    Check dated 2025-11-23T07:56:42.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.